Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Animal models of Parkinson׳s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535).

Stasi MA, Minetti P, Lombardo K, Riccioni T, Caprioli A, Vertechy M, Di Serio S, Pace S, Borsini F.

Eur J Pharmacol. 2015 Aug 15;761:353-61. doi: 10.1016/j.ejphar.2015.03.070. Epub 2015 Apr 30.

PMID:
25936513
2.

Design, synthesis, and structure-activity relationship of N-arylnaphthylamine derivatives as amyloid aggregation inhibitors.

Di Santo R, Costi R, Cuzzucoli Crucitti G, Pescatori L, Rosi F, Scipione L, Celona D, Vertechy M, Ghirardi O, Piovesan P, Marzi M, Caccia S, Guiso G, Giorgi F, Minetti P.

J Med Chem. 2012 Oct 11;55(19):8538-48. doi: 10.1021/jm301105m. Epub 2012 Oct 1.

PMID:
22966981
3.

The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models.

Caprioli A, Coccurello R, Rapino C, Di Serio S, Di Tommaso M, Vertechy M, Vacca V, Battista N, Pavone F, Maccarrone M, Borsini F.

J Pharmacol Exp Ther. 2012 Jul;342(1):188-95. doi: 10.1124/jpet.111.191403. Epub 2012 Apr 18.

PMID:
22514334
4.

ST2472: a new potential antipsychotic with very low liability to induce side-effects.

Stasi MA, Di Serio S, Vertechy M, Schiavone A, Ghirardi O, Minetti P, Campiani G, Borsini F, Carminati P.

Int J Neuropsychopharmacol. 2008 May;11(3):309-19. Epub 2007 Oct 10.

PMID:
17925059
5.

Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.

Ghirardi O, Lo Giudice P, Pisano C, Vertechy M, Bellucci A, Vesci L, Cundari S, Miloso M, Rigamonti LM, Nicolini G, Zanna C, Carminati P.

Anticancer Res. 2005 Jul-Aug;25(4):2681-7.

6.

Chemotherapy-induced allodinia: neuroprotective effect of acetyl-L-carnitine.

Ghirardi O, Vertechy M, Vesci L, Canta A, Nicolini G, Galbiati S, Ciogli C, Quattrini G, Pisano C, Cundari S, Rigamonti LM.

In Vivo. 2005 May-Jun;19(3):631-7.

7.

Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.

Campiani G, Butini S, Fattorusso C, Catalanotti B, Gemma S, Nacci V, Morelli E, Cagnotto A, Mereghetti I, Mennini T, Carli M, Minetti P, Di Cesare MA, Mastroianni D, Scafetta N, Galletti B, Stasi MA, Castorina M, Pacifici L, Vertechy M, Di Serio S, Ghirardi O, Tinti O, Carminati P.

J Med Chem. 2004 Jan 1;47(1):143-57.

PMID:
14695828
8.

L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors.

Chiechio S, Caricasole A, Barletta E, Storto M, Catania MV, Copani A, Vertechy M, Nicolai R, Calvani M, Melchiorri D, Nicoletti F.

Mol Pharmacol. 2002 May;61(5):989-96.

PMID:
11961116
9.

The effect of age on the activity of enzymes of peroxide metabolism in rat brain.

Vertechy M, Cooper MB, Ghirardi O, Ramacci MT.

Exp Gerontol. 1993 Jan-Feb;28(1):77-85.

PMID:
8382167
10.

Ordered disorder in the aged brain.

Angelucci L, Alemà S, Ferraris L, Ghirardi O, Imperato A, Ramacci MT, Scrocco MG, Vertechy M.

Adv Exp Med Biol. 1991;296:277-90. No abstract available.

PMID:
1781334
11.

Antioxidant enzyme activities in heart and skeletal muscle of rats of different ages.

Vertechy M, Cooper MB, Ghirardi O, Ramacci MT.

Exp Gerontol. 1989;24(3):211-8.

PMID:
2543589

Supplemental Content

Loading ...
Support Center